当前位置:循环首页>正文

[ACC2010]合并糖尿病的冠心病患者预后治疗心得--Steven P. Marso教授专访

作者:国际循环网   日期:2010/3/16 18:11:00

国际循环网版权所有,谢绝任何形式转载,侵犯版权者必予法律追究。

You have mentioned that diabetes is very much associated with poor outcomes in coronary heart disease patients. Please address the best methods in choosing therapy agents for those heart disease patients with Diabetes. ......

<International Circulation>: What is the appropriate blood glucose level in different heart disease patient subgroups such as congestive heart failure or acute coronary syndrome?

Prof Marso: If you take the current guidelines, the ADA currently recommends a HbA1c of less than 7% in people with type 2 diabetes. In fact, if you can get an individual down to 6%, it is beneficial. First way I would answer that question is to try and manage chronic glycemia down to about 7% HbA1c. In-hospital management is a lot more problematic. It is not clear to me that we should employ aggressive strategies to lower glucose levels in the hospital. There are a variety of epidemiological studies that suggest it may be helpful but there has been no intervention trial to educate me or enable me to do that as a provider safely and effectively and to what benefit.

上一页  [1]  [2]  [3]  [4]  [5]  下一页

版面编辑:解晓东



合并糖尿病冠心病

分享到: 更多


设为首页 | 加入收藏 | 关于我们 | 联系方式 | 招贤纳士
声明:国际循环网( www.icirculation.com)对刊载的所有文章、视频、幻灯、音频等资源拥有全部版权。未经本站许可,不得转载。
京ICP备15014970号-5  互联网药品信息服务资格证书编号(京)-非经营性-2017-0063  京公网安备 11010502033353号  增值电信业务经营许可证:京ICP证150541号
国际循环 版权所有   © 2004-2024 www.icirculation.com All Rights Reserved
公司名称:北京美赞广告有限公司 公司地址:北京市朝阳区朝阳门北大街乙12号天辰大厦1座1409 电话:010-51295530